[go: up one dir, main page]

BR9917002A - Materials and processes for the modification of isoprenoid content, composition and metabolism - Google Patents

Materials and processes for the modification of isoprenoid content, composition and metabolism

Info

Publication number
BR9917002A
BR9917002A BR9917002-7A BR9917002A BR9917002A BR 9917002 A BR9917002 A BR 9917002A BR 9917002 A BR9917002 A BR 9917002A BR 9917002 A BR9917002 A BR 9917002A
Authority
BR
Brazil
Prior art keywords
metabolism
processes
content
composition
materials
Prior art date
Application number
BR9917002-7A
Other languages
Portuguese (pt)
Inventor
Ilkka Jaakko Havukkala
Original Assignee
Genesis Res & Dev Corp Ltd
Letcher Challange Forests Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Res & Dev Corp Ltd, Letcher Challange Forests Ltd filed Critical Genesis Res & Dev Corp Ltd
Publication of BR9917002A publication Critical patent/BR9917002A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8255—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving lignin biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Patente de Invenção: "MATERIAIS E PROCESSOS PARA AMODIFICAçãO DE TEOR, COMPOSIçãO E METABOLISMO DEISOPRENóIDES". Novos polinucleotídeos isolados associadoscom vias biossintéticas de isoprenóides são providos, junto comconstruções genéticas compreendendo estas seq³ências. Osprocessos para a modulação do teor, estrutura e metabolismo dospolipeptídeos envolvidos na via biossintética de isoprenóides emorganismos alvos são também descritos, os métodoscompreendendo a incorporação de um ou mais dospolinucleotídeos ou construções genéticas da presente invençãono genoma de um organismo alvo. A modulação do teor, estruturae metabolismo destes polipeptídeos produzem modificações noteor, estrutura e metabolismo dos isoprenóides no organismo alvo.Invention Patent: "MATERIALS AND PROCESSES FOR AMODIFICATION OF DEISOPRENOID CONTENT, COMPOSITION AND METABOLISM". New isolated polynucleotides associated with isoprenoid biosynthetic pathways are provided, along with genetic constructions comprising these sequences. Processes for modulating the content, structure and metabolism of polypeptides involved in the isoprenoid biosynthetic pathway in target organisms are also described, methods including the incorporation of one or more dospolinucleotides or genetic constructs of the present invention into the genome of a target organism. The modulation of the content, structure and metabolism of these polypeptides produces significant changes, structure and metabolism of isoprenoids in the target organism.

BR9917002-7A 1998-12-17 1999-12-16 Materials and processes for the modification of isoprenoid content, composition and metabolism BR9917002A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21550498A 1998-12-17 1998-12-17
US14644199P 1999-07-29 1999-07-29
PCT/NZ1999/000219 WO2000036081A2 (en) 1998-12-17 1999-12-16 Materials and methods for the modification of isoprenoid content, composition and metabolism

Publications (1)

Publication Number Publication Date
BR9917002A true BR9917002A (en) 2001-12-04

Family

ID=26843909

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9917002-7A BR9917002A (en) 1998-12-17 1999-12-16 Materials and processes for the modification of isoprenoid content, composition and metabolism

Country Status (10)

Country Link
EP (1) EP1151081A2 (en)
JP (1) JP2002541764A (en)
CN (1) CN1334866A (en)
AR (1) AR021636A1 (en)
AU (1) AU1900100A (en)
BR (1) BR9917002A (en)
CA (1) CA2353910A1 (en)
ID (1) ID29580A (en)
MX (1) MXPA01006009A (en)
WO (1) WO2000036081A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4793963B2 (en) * 1998-10-09 2011-10-12 アーバーゲン インコーポレイテッド Materials and methods for modifying plant lignin content
CZ20022366A3 (en) 2000-10-06 2003-04-16 Sapporo Breweries Limited Farnesyl pyrophosphate synthase proteins, nucleic acid and promoter regions thereof
DE10057755A1 (en) 2000-11-22 2002-05-23 Bayer Ag New nucleic acid encoding plant phosphomevalonate kinase, useful for identifying modulators, potentially useful as herbicides and growth regulators
US20030217384A1 (en) * 2002-02-05 2003-11-20 Harvell Leslie T. Obtusifoliol 14a-demethylase
US20040010818A1 (en) * 2002-05-09 2004-01-15 Mcgonigle Brian Transgenic plants with a suppressed triterpene level
US7402428B2 (en) 2004-09-22 2008-07-22 Arborgen, Llc Modification of plant lignin content
WO2009032943A2 (en) * 2007-09-04 2009-03-12 Affinergy, Inc. Methods and compositions for delivery of growth factor to fibrous connective tissue
MY167872A (en) 2010-06-02 2018-09-26 Evolva Inc Recombinant production of steviol glycosides
US9631215B2 (en) 2011-08-08 2017-04-25 Evolva Sa Recombinant production of steviol glycosides
SG11201505597SA (en) 2013-02-06 2015-08-28 Evolva Sa Methods for improved production of rebaudioside d and rebaudioside m
CA2900882A1 (en) 2013-02-11 2014-08-14 Evolva Sa Efficient production of steviol glycosides in recombinants hosts
CN106572688B (en) 2014-08-11 2022-01-25 埃沃尔瓦公司 Production of steviol glycosides in recombinant hosts
EP3190905B1 (en) 2014-09-09 2025-03-12 Danstar Ferment AG Production of steviol glycosides in recombinant hosts
JP2018503388A (en) 2015-01-30 2018-02-08 エヴォルヴァ エスアー．Ｅｖｏｌｖａ Ｓａ． Production of steviol glycosides in recombinant hosts
EP3271457B1 (en) 2015-03-16 2021-01-20 DSM IP Assets B.V. Udp-glycosyltransferases
CA2995067A1 (en) 2015-08-07 2017-02-16 Evolva Sa Production of steviol glycosides in recombinant hosts
CN109195457A (en) 2016-04-13 2019-01-11 埃沃尔瓦公司 Steviol glycoside is generated in the recombination host
EP3458599A1 (en) 2016-05-16 2019-03-27 Evolva SA Production of steviol glycosides in recombinant hosts
WO2018083338A1 (en) 2016-11-07 2018-05-11 Evolva Sa Production of steviol glycosides in recombinant hosts
WO2020097588A1 (en) 2018-11-09 2020-05-14 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265639B1 (en) * 1998-01-22 2001-07-24 Washington State University Foundation Gymnosperm nucleic acid molecules encoding sesquiterpene synthases and methods of use

Also Published As

Publication number Publication date
WO2000036081A2 (en) 2000-06-22
CA2353910A1 (en) 2000-06-22
MXPA01006009A (en) 2002-04-15
WO2000036081A3 (en) 2000-08-03
JP2002541764A (en) 2002-12-10
ID29580A (en) 2001-09-06
AR021636A1 (en) 2002-07-31
CN1334866A (en) 2002-02-06
AU1900100A (en) 2000-07-03
EP1151081A2 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
BR9917002A (en) Materials and processes for the modification of isoprenoid content, composition and metabolism
BR9915021A (en) Materials and methods for modifying plant lignin content
BR9711745A (en) Materials and processes for modifying plant lignin content.
Sihag et al. Phosphorylation of the amino-terminal head domain of the middle molecular mass 145-kDa subunit of neurofilaments. Evidence for regulation by second messenger-dependent protein kinases.
Tudek Base excision repair modulation as a risk factor for human cancers
O'Donovan et al. Isolation of active recombinant XPG protein, a human DNA repair endonuclease.
Sancar et al. Action mechanism of Escherichia coli DNA photolyase. I. Formation of the enzyme-substrate complex.
BR9812079A (en) Salmonella sp. mutant, lipopolysaccharide, process to inhibit the growth or reduce the volume of a solid tumor cancer, pharmaceutical composition, and, improved process to select genetic alterations in a bacterium.
AU1458395A (en) Composition containing nucleic acids, preparation and uses
BR9712978A (en) Non-mammalian DNA viruses having an altered coating protein
AU4835396A (en) Composition containing nucleic acids, preparation and use
PT980263E (en) A COMBINATION PRODUCT ASSOCIATING A NUCLEIC ACID TO A DEFROSTING SUBSTANCE OF THE EXTRACELLULAR MATRIX FOR GENETIC THERAPY
BR9814814A (en) Processes for modulating serine / threonine protein kinase function with 5-azaquinoxaline-based compounds
WO1999054459A8 (en) Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
MX9700270A (en) Nucleic acid containing composition, preparation and uses of same.
BR0008091A (en) Wound suture material, and, material
BR9911861A (en) Farnesyl protein transferase inhibitors with radiosensitizing properties in vivo
AU5102299A (en) Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages
BR9910573A (en) Antipicornoviral compounds, preparation and use thereof
BR0007035A (en) Pest control methods for agrotides
BR9809364A (en) Regulation metabolism by modifying the level of trehalose-6-phosphate by inhibiting endogenous trehalase levels
BR9908412A (en) Stabilized enzymatic composition and method for its preparation
George et al. Inhibition of DNA helicase II unwinding and ATPase activities by DNA-interacting ligands. Kinetics and specificity.
Pedrali-Noy et al. Mammalian DNA methyltransferases prefer poly (dI-dC) as substrate.
BR9810703A (en) Pharmaceutical composition, and processes for preparing it, and for treating a platelet aggregation disorder

Legal Events

Date Code Title Description
TC Change of name
TE Change of address
B25A Requested transfer of rights approved

Free format text: GENESIS RESEARCH & DEVELOPMENT CORPORATION LIMITED (NZ), RUBICON FORESTS HOLDINGS LIMITED (NZ)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A,8A,9A E 10A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009.